Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $133.4400 (-3.28%) ($131.1000 - $135.2600) on Thu. Jun. 1, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.47% (three month average) | RSI | 19 | Latest Price | $133.4400(-3.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.1% a day on average for past five trading days. | Weekly Trend | ABBV declines -3.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) IBB(16%) XBI(14%) XLU(13%) XOP(13%) IDRV(10%) | Factors Impacting ABBV price | ABBV will decline at least -0.735% in a week (0% probabilities). EDOC(-17%) BWX(-15%) IPO(-12%) BNDX(-12%) XLC(-11%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.735% (StdDev 1.47%) | Hourly BBV | -1.2 () | Intraday Trend | -1.2% | | | |
|
Resistance Level | $142.96 | 5 Day Moving Average | $136.8(-2.46%) | 10 Day Moving Average | $139.89(-4.61%) | 20 Day Moving Average | $142.96(-6.66%) | To recent high | -19.1% | To recent low | 0% | Market Cap | $235.426b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |